ABIM Palliative Care common mistakes
ABIM Palliative Care · Understand the traps and how to avoid them.
When switching opioids, the candidate calculates a new dose from an equianalgesic table and prescribes 100% of that calculated dose, then moves on without a planned reassessment.
Equianalgesic tables are population averages derived largely from single-dose or chronic-dosing studies; individual variability and incomplete cross-tolerance mean the full calculated dose can cause oversedation and respiratory depression, especially in older adults, renal impairment, or high-dose regimens. Candidates memorize the numbers as if they were exact conversions.
What to do instead
Treat the table value as a starting estimate only: reduce the calculated equianalgesic dose by 25-50% (more with high baseline doses, frailty, or renal/hepatic impairment), prescribe rescue doses at 10-15% of the total daily dose, and document a reassessment plan within 24 hours and after 2-3 doses. Also check the direction of the conversion and account for methadone and transdermal fentanyl, which do not follow linear ratios.
The candidate picks an antiemetic reflexively (usually ondansetron) for every nausea vignette, without identifying the likely mechanism or checking the medication list and bowel history first.
Board-style chemotherapy teaching anchors 5-HT3 antagonists as 'the antiemetic,' and candidates default to the familiar drug instead of reasoning mechanistically. Opioid-induced constipation, gastric stasis, raised intracranial pressure, vestibular causes, and metabolic causes each respond to different agents.
What to do instead
Work through a mechanism checklist: constipation (treat the bowel, add osmotic laxative), gastric stasis or functional obstruction (metoclopramide, only if no complete obstruction), vestibular (scopolamine, antihistamine), raised ICP (dexamethasone, sometimes plus metoclopramide), metabolic/uremic (haloperidol), chemotherapy-related (5-HT3 plus dexamethasone plus NK1 antagonist). State the presumed mechanism explicitly before choosing the drug, and avoid prokinetics in complete bowel obstruction.
The candidate misses delirium in a quiet, withdrawn older patient and, when delirium is recognized, selects a benzodiazepine as first-line pharmacologic treatment.
The mental image of delirium is the agitated, hyperactive patient, so the hypoactive and mixed subtypes are under-recognized and mislabeled as depression, fatigue, or 'just dying.' Benzodiazepines are over-learned as calming agents, but they worsen most delirium by increasing confusion and falls.
What to do instead
Screen actively with a validated tool such as the CAM or 4AT in any patient with new inattention, fluctuating behavior, or functional decline. Search for reversible contributors (opioids, anticholinergics, steroids, urinary retention, constipation, dehydration, infection, hypoxia, sleep deprivation, sensory impairment) and start non-pharmacologic measures first. Reserve antipsychotics such as haloperidol or an atypical for distressing agitation or psychosis at the lowest effective dose, and use benzodiazepines only for alcohol or sedative withdrawal delirium.
When a patient cries or expresses fear after hearing bad news, the candidate immediately supplies more medical information, statistics, or a plan.
Clinicians are trained to solve problems and feel discomfort with strong emotion; filling the silence with data relieves the clinician's anxiety, not the patient's. The result is a patient who feels unheard and stops disclosing what actually worries them.
What to do instead
Respond to the emotion before the content: name it ('I can see this is frightening'), legitimize it, and pause long enough to allow the patient to continue, then explore ('what concerns you most right now?'). Use a structured approach such as NURSE (naming, understanding, respecting, supporting, exploring) and ask permission before giving more information. Only after the emotion is acknowledged should the candidate return to facts and shared decision-making.
The candidate documents that a patient 'lacks capacity' because the patient refuses the recommended treatment, or performs a one-question assessment such as 'do you understand?' and counts it as a capacity evaluation.
Refusal of a clinician's recommendation feels like impaired reasoning, and capacity is often confused with compliance or with the legal standard of competence. A single question cannot demonstrate the four functional abilities and may be confounded by hearing, language, delirium, or depression.
What to do instead
Assess the four abilities explicitly and document each: communicating a choice, understanding the relevant information (teach-back in the patient's language and with hearing or vision aids), appreciating the situation and consequences, and reasoning about options. Treat capacity as decision-specific and time-specific, identify and treat reversible contributors such as delirium or depression, and involve a surrogate only when the patient truly cannot decide. Refusal after an adequate assessment is a value choice, not a capacity deficit.
The candidate under-treats dyspnea or pain in an imminently dying patient - for example, ordering oxygen but avoiding or under-dosing morphine - out of fear of hastening death.
The belief that opioids cause death in dying patients is widespread and is reinforced by the misconception that double effect requires intending harm. Candidates therefore accept untreated air hunger as unavoidable and substitute ineffective interventions such as oxygen in a normoxemic patient.
What to do instead
Treat dyspnea with opioids titrated to symptom relief, starting low (for an opioid-naive patient, small doses of morphine or equivalent) and reassessing frequently; use a fan or open window for airflow, and give oxygen only for documented hypoxemia. Apply double effect correctly: the intent is relief of suffering, the dose is proportionate and titrated to response, and death from underlying disease is foreseen but not intended. Escalating doses to relieve refractory symptoms in the last hours are ethically and legally appropriate.
The candidate fails to recognize the actively dying phase and continues disease-directed monitoring and medications - daily labs, glucose checks, statins, bisphosphonates, antihypertensives, transfusions - while deferring hospice referral or the comfort-focused conversation.
Dying is a clinical diagnosis taught far less than disease management, and each abnormal lab invites another intervention. Prognostic uncertainty is used as a reason to wait, and deprescribing feels like giving up rather than active care.
What to do instead
Recognize the syndrome of impending death: progressive weakness and bedbound status, reduced oral intake, drowsiness or delirium, mottled extremities, Cheyne-Stokes breathing, and changes over days to hours. Then act: stop non-beneficial monitoring and preventive medications, convert essential drugs to comfort routes, treat secretions, pain, dyspnea, and agitation, address the family's questions, and make the hospice or comfort-focused plan explicit. Frame deprescribing as part of the care plan rather than as withdrawal.
The candidate applies oncology-style hospice criteria and a linear decline model to a patient with heart failure, COPD, cirrhosis, or dialysis-dependent renal disease, and concludes the patient is 'not yet eligible' or 'not ready' for hospice.
Cancer teaching dominates palliative care education, so the trajectory of steady decline with a clear terminal phase is over-applied. Organ failure produces a sawtooth course of exacerbations and partial recoveries, which makes prognosis feel impossible and leads to late or absent hospice referral.
What to do instead
Learn disease-specific hospice eligibility markers (for example, NYHA class IV symptoms with ejection fraction or BNP criteria, disabling dyspnea with FEV1 or oxygen dependence plus prior hospitalizations or ICU use, advanced cirrhosis with ascites, encephalopathy or varices, and renal failure with poor performance status plus declining oral intake). Recognize the organ-failure trajectory with sudden deaths interspersed with partial recoveries, start advance care planning early and revisit it after each exacerbation, and refer when the trajectory plus symptom burden and functional decline meet criteria.
In a pediatric or adolescent vignette, the candidate calculates an opioid or other medication dose from an adult fixed dose or adult starting dose, and holds goals-of-care discussion with the parents only, excluding the child.
Adult-focused training makes weight-based pediatric dosing and developmental communication feel like a separate specialty. Candidates also assume that discussing serious illness with a child causes harm, so they default to shielding the child and speaking only to the parents.
What to do instead
Calculate all doses by weight (mg/kg) with maximum-dose checks, and remember that opioid-naive children need small, carefully titrated doses. Ask the child what they already know and want to know, using developmentally appropriate language; adolescents should be included in decisions and, in many jurisdictions, may have legal standing for certain decisions. Support siblings and recognize that parents are also patients of the team.
The candidate blurs hospice and palliative care eligibility, assumes a palliative care consult must address prognosis or that hospice requires stopping all treatments, and cannot state the roles of the interdisciplinary team members or how advance care plans are documented and retrieved.
Hospice and palliative care are taught as synonyms, and the regulatory details feel like administrative trivia rather than clinical knowledge. Team roles are likewise learned as a list of disciplines rather than as distinct scopes of practice.
What to do instead
State the distinctions precisely: palliative care is symptom and goals-directed care at any stage and alongside disease-directed therapy; hospice in the United States requires a prognosis of six months or less if the disease runs its usual course, with recertification at benefit periods, and permits comfort-focused treatments while forgoing curative intent. Know that chaplains address spiritual and existential distress, social workers address psychosocial and resource needs, and pharmacists address complex regimens. Confirm that the advance care plan is documented in a retrievable, portable form and communicated to the team and surrogate.